Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Cyclacel Pharmaceuticals Inc    CYCC   US23254L3069

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/23/2014 07/24/2014 07/25/2014 07/28/2014 07/29/2014 Date
3.13(c) 3.1(c) 3.11(c) 3.09(c) 3.11 Last
44 573 56 078 66 742 54 290 7 332 Volume
+1.29% -0.96% +0.32% -0.64% +0.65% Change
More quotes
Company
Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases. Its most advance product candidate, is the subject of SEAMLESS, a phase 3 trail being... 
Surperformance© rating of Cyclacel Pharmaceuticals I
Trading Rating : - Investor Rating :
More about the company
Chart CYCLACEL PHARMACEUTICALS I
Duration : Period :
Cyclacel Pharmaceuticals I Technical Analysis Chart | CYCC | US23254L3069 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 0,40 M
EBIT 2014 -24,9 M
Net income 2014 -24,6 M
Debt 2014 -
Yield 2014 -
Sales 2015 0,23 M
EBIT 2015 -29,5 M
Net income 2015 -29,4 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 176x
Capi. / Sales 2015 311x
Capitalization 70,1 M
More Financials
Latest news on CYCLACEL PHARMACEUTICALS I
06/17 CYCLACEL PHARMACEUTICALS : to Present at 9th Annual JMP Securities Healthcare Co..
05/31 CYCLACEL PHARMACEUTICALS : Provides Update on Its Clinical Development Plan of S..
05/28 CYCLACEL PHARMACEUTICALS : to Webcast Institutional Investor and Analyst Present..
05/28 CYCLACEL PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K)
05/23 CYCLACEL PHARMACEUTICALS : Submission of Matters to a Vote of Security Holders, ..
05/13 CYCLACEL PHARMACEUTICALS : Management's Discussion and Analysis of Financial Con..
05/13 CYCLACEL PHARMACEUTICALS : Results of Operations and Financial Condition, Financ..
05/13 Cyclacel Pharmaceuticals Reports First Quarter 2014 Financial Results
05/06 CYCLACEL PHARMACEUTICALS : to Release 2014 First Quarter Financial Results
05/05 CYCLACEL PHARMACEUTICALS : New Japanese Patents Issued Covering Sapacitabine Pha..
04/10 CYCLACEL PHARMACEUTICALS : Independent Investigators Present Non-Clinical Data P..
04/09 CYCLACEL PHARMACEUTICALS : Announces Closing of $10 Million Underwritten Offerin..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
Cyclacel Pharmaceuticals I : Income Statement Evolution
More Financials
EPS Revisions
Cyclacel Pharmaceuticals I : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF